8-K: Teladoc Health Reports Mixed Full Year and Q4 2024 Results, Initiates 2025 Guidance

Teladoc Health's full year 2024 revenue declined slightly, with a significant increase in net loss, while the company initiates 2025 guidance including the anticipated contribution from the acquisition of Catapult Health.

Summary

• Teladoc Health reported full year 2024 revenue of $2,569.6 million, a 1% decrease year-over-year.
• Fourth quarter 2024 revenue was $640.5 million, down 3% year-over-year.
• The full year 2024 net loss was $1,001.2 million, or $5.87 per share, compared to a net loss of $220.4 million in the previous year.
• Fourth quarter 2024 net loss was $48.4 million, or $0.28 per share.
• Adjusted EBITDA for the full year 2024 was $310.7 million, a 5% decrease year-over-year.
• Adjusted EBITDA for the fourth quarter 2024 was $74.8 million, down 35% year-over-year.
• Full year 2024 operating cash flow was $293.7 million, down from $350.0 million in the prior year.
• Free cash flow for the full year 2024 was $169.6 million, down from $193.7 million.
• The company's cash position was $1,298.3 million as of December 31, 2024.
• Teladoc Health has initiated 2025 guidance, projecting revenue between $2,468 and $2,576 million and adjusted EBITDA between $278 and $319 million.
• The company expects a net loss per share between ($1.10) and ($0.50) for 2025.
• Free cash flow for 2025 is projected to be between $190 and $220 million.
• The company anticipates U.S. Integrated Care Members to be between 101 and 103 million in 2025.
• For the first quarter of 2025, revenue is expected to be between $608 and $629 million, and adjusted EBITDA between $47 and $59 million.
• The company expects a net loss per share between ($0.40) and ($0.15) for the first quarter of 2025.
• U.S. Integrated Care Members are expected to be between 101 and 102 million for the first quarter of 2025.

Sentiment

Score: 5

Explanation: The sentiment is neutral to slightly negative. While there are some positive aspects, such as international revenue growth and the Catapult Health acquisition, the significant increase in net loss and decrease in adjusted EBITDA weigh negatively on the overall outlook.

Positives

• International revenue grew by 12% for both the fourth quarter and full year 2024.
• Integrated Care segment revenue increased by 4% for the full year 2024.
• Integrated Care segment adjusted EBITDA increased 21% to $232.9 million for the year ended December 31, 2024.
• The company's cash position was $1,298.3 million as of December 31, 2024.
• Teladoc Health is acquiring Catapult Health, which is expected to contribute to future financial performance.
• The company is focused on cost structure improvements, building on achievements in 2024.

Negatives

• Full year 2024 revenue decreased by 1% to $2,569.6 million.
• Net loss for full year 2024 significantly increased to $1,001.2 million, or $5.87 per share.
• Adjusted EBITDA for full year 2024 decreased by 5% to $310.7 million.
• BetterHelp segment revenue decreased by 8% for the full year 2024.
• BetterHelp segment adjusted EBITDA decreased 43% to $77.8 million for the year ended December 31, 2024.
• The company recorded a non-cash goodwill impairment charge of $790.0 million related to the BetterHelp segment.
• Operating cash flow and free cash flow decreased for the full year 2024.

Risks

• The operating environment for BetterHelp remains challenging.
• The company's future financial performance is subject to various risks and uncertainties, including changes in laws and regulations, market conditions, and litigation outcomes.
• The company's ability to recruit and retain qualified providers into its network could impact results.
• The success of the company's operational review to achieve a more balanced approach to growth and margin is uncertain.
• The company's 2025 guidance is based on current market conditions and expectations, which are subject to change.

Future Outlook

Teladoc Health anticipates revenue between $2,468 and $2,576 million and adjusted EBITDA between $278 and $319 million for the full year 2025, including the anticipated contribution from the acquisition of Catapult Health.

Management Comments

• Chuck Divita, CEO, stated that the company had a solid finish to the year and progressed well on key priorities.
• Divita noted the challenging operating environment for BetterHelp and the focus on stabilizing results.
• Divita emphasized that execution will be a top priority in 2025 to unlock growth opportunities and position the company for long-term success.
• Divita believes the company is setting a stronger foundation to drive the business forward.

Industry Context

Teladoc Health's results reflect the ongoing challenges and opportunities in the virtual care market, including increased competition and evolving consumer preferences. The acquisition of Catapult Health suggests a strategic focus on expanding integrated care offerings.

Comparison to Industry Standards

• It is difficult to compare Teladoc's results directly to industry standards without specific competitor data.
• However, the decrease in revenue and adjusted EBITDA, coupled with a significant net loss, suggests that Teladoc is facing challenges in maintaining growth and profitability compared to some other players in the telehealth space.
• Companies like Amwell and Optum (UnitedHealth Group) are key competitors, but their financial reporting structures may differ, making direct comparisons difficult.
• The BetterHelp segment's struggles highlight the competitive pressures in the virtual mental health market, where companies like Talkspace and Cerebral also operate.

Stakeholder Impact

• Shareholders will be concerned about the increased net loss and decreased adjusted EBITDA.
• Employees may be affected by the company's focus on cost structure improvements.
• Customers may see changes in service offerings as the company integrates Catapult Health and addresses challenges in the BetterHelp segment.
• Suppliers and creditors may be impacted by the company's financial performance and strategic direction.

Next Steps

• The company will hold an earnings conference call and webcast on February 26, 2025.
• The company will focus on executing its 2025 plan, including integrating Catapult Health and improving the performance of the BetterHelp segment.

Key Dates